Stock Market Reviews

ANGO (AngioDynamics, Inc.) News

Get the latest news, insights, and market updates on ANGO (AngioDynamics, Inc.). Explore the news page 5 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
  AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
  Oct 2, 2025 - $ANGO
• Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
  ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
  Sep 22, 2025 - $ANGO
• AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
  LATHAM, N.Y., September 18, 2025--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the first quarter of fiscal year 2026 before the market open on Thursday, October 2, 2025. The Company’s management will host a conference call at 8:00 am ET the same day
  Sep 18, 2025 - $ANGO
• Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates
  Nutriband (NTRB) delivered earnings and revenue surprises of -1,147.06% and -11.77%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
  Sep 9, 2025 - $ANGO
• With AngioDynamics Up 11%, Insider Buyers Count Their Returns
  AngioDynamics, Inc. ( NASDAQ:ANGO ) insiders who bought shares over the past year were rewarded handsomely last week...
  Aug 27, 2025 - $ANGO
• Europe Neonatal Intensive Care Market Growth and Company Analysis Report 2025-2033 Featuring Masimo, 3M, Medtronic, Koninklijke Philips, Siemens, Terumo, AngioDynamics, Dragerwerk
  The Europe Neonatal Intensive Care Market is poised to grow from US$ 1.04 billion in 2024 to US$ 1.60 billion by 2033, boasting a CAGR of 4.96%. This growth is propelled by rising preterm birth rates, neonatal technology advancements, government regulations, and expanding hospital infrastructure, particularly in Eastern Europe. Key sectors include incubators, ventilators, and monitoring devices. Countries like Germany, France, and the UK are leading due to their robust NICU facilities and height
  Aug 14, 2025 - $ANGO
• AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
  LATHAM, N.Y., August 06, 2025--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 45th Annual Growth Conference at 9:00
  Aug 6, 2025 - $ANGO
• AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
  LATHAM, N.Y., July 28, 2025--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first patient in the Randomized Study of the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Treating Infrapopliteal Lesions in Subjects with Critical Li
  Jul 28, 2025 - $ANGO